EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of the Moderna COVID-19 Vaccine in Adolescents (12-17 Years of Age) in the European UnionBusiness Wire • 07/23/21
Moderna to supply 35 million more doses of its COVID-19 vaccine to Taiwan in 2022 and 2023Market Watch • 07/22/21
Moderna Announces New Supply Agreement with Taiwan for 20 Million Doses of Moderna's COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022 and 15 Million Doses in 2023Business Wire • 07/22/21
How in the World Is Moderna Valued at More Than Half of Pfizer's Market Cap?The Motley Fool • 07/22/21
Lexaria Stock Is Trading Higher As DehydraTECH Delivered Colchicine Can Potentially Treat COVID-19, Side Effects From mRNA ShotsBenzinga • 07/21/21
Moderna partners with Takeda, Japanese government on additional 50 million COVID-19 vaccine dosesMarket Watch • 07/20/21
Moderna Partners with Takeda and the Government of Japan to Supply Additional 50 Million Doses of Moderna's COVID-19 Vaccine and Variant Booster Vaccine Candidate in 2022Business Wire • 07/20/21